+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Carbetocin Market by Indication (Prevention of Postpartum Hemorrhage, Treatment of Postpartum Hemorrhage), Formulation (Prefilled Syringe, Vial), Route of Administration, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Carbetocin Market by Indication (Prevention of Postpartum Hemorrhage, Treatment of Postpartum Hemorrhage), Formulation (Prefilled Syringe, Vial), Route of Administration, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Carbetocin Market by Indication (Prevention of Postpartum Hemorrhage, Treatment of Postpartum Hemorrhage), Formulation (Prefilled Syringe, Vial), Route of Administration, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010691
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives seeking reliable insights on postpartum hemorrhage management will find the Carbetocin Market analysis essential for informed strategic decision-making. This report delivers an in-depth view of market drivers, evolving regulatory dynamics, and impactful innovations shaping therapeutic standards for maternal health interventions.

Market Snapshot: Carbetocin Market Size and Growth Outlook

The Carbetocin Market grew from USD 211.76 million in 2024 to USD 224.63 million in 2025. It is expected to continue growing at a CAGR of 5.90%, reaching USD 298.85 million by 2030. This sustained growth underlines increasing global adoption of carbetocin, a clinically significant therapy for postpartum hemorrhage, and reflects expanding demand across advanced and emerging healthcare systems.

Scope & Segmentation Analysis

  • Indication: Prevention and treatment of postpartum hemorrhage across cesarean section and vaginal delivery contexts.
  • Formulation Types: Prefilled syringes and vials support diverse procurement and administration needs.
  • Route of Administration: Options include intramuscular and intravenous delivery pathways.
  • End User Environments: Birthing centers, clinics, and hospitals each present unique operational requirements for product integration.
  • Distribution Channels: Hospital pharmacies and retail pharmacies serve as primary conduits to end users.
  • Regional Coverage: Comprehensive assessments span the Americas (including key U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (notably the UK, Germany, France, Russia, Italy, UAE, South Africa, and more), plus Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and others).
  • Leading Companies Profiled: Ferring Pharmaceuticals, Fresenius Kabi AG, Gland Pharma Limited, Intas Pharmaceuticals Limited, Merck & Co., Inc., Pfizer Inc., Haffkine Bio-Pharmaceutical Corporation Limited, Cipla Limited, Sun Pharmaceutical Industries Limited, Zhejiang Jingxin Pharmaceutical Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Carbetocin’s role is expanding beyond initial prophylaxis; evidence supports both preventive and active management of postpartum hemorrhage in clinical practice.
  • Innovations such as prefilled syringes are enhancing both dosing accuracy and cold-chain independence, which increases accessibility in lower-resource settings.
  • Recent international regulatory acceptances and inclusion in health frameworks are accelerating clinical adoption and prompting protocol modernization worldwide.
  • Strategic partnerships between pharmaceutical companies, non-profit entities, and public health agencies are enabling broader distribution and program reach.
  • Diverse care settings, from tertiary hospitals to outpatient clinics, require tailored approaches to training, inventory, and supply logistics for optimal maternal health outcomes.
  • Competitive market dynamics are intensifying, with the entry of generics and increased collaborations, resulting in more options for institutional procurement and cost containment.

Tariff Impact: Navigating Supply Chain and Pricing Challenges

Recent U.S. trade policies have introduced tariffs affecting pharmaceutical supply chains, including those for carbetocin. Manufacturers have adjusted sourcing strategies—such as dual-sourcing and nearshoring—to reduce disruptions, while healthcare providers and distributors are optimizing inventory management to maintain clinical availability. These changes demand careful review of contract structures, fiscal planning, and resilience in maternal health program design.

Methodology & Data Sources

This report leverages a robust research methodology encompassing secondary data synthesis from peer-reviewed studies and regulatory sources, complemented by expert interviews with industry stakeholders, providers, and supply chain professionals. Triangulation techniques ensure data reliability and nuanced insights relevant for executive-level decisions.

Why This Report Matters

  • Provides clear, actionable intelligence to help leaders optimize resource allocation, partnership strategies, and policy engagement around carbetocin market integration.
  • Enables risk management by detailing operational, regulatory, and competitive factors shaping global access to maternal health therapies.
  • Supports procurement and investment planning tailored to regional priorities, infrastructural realities, and emerging healthcare trends.

Conclusion

Carbetocin’s emergence as a preferred option for postpartum hemorrhage management is reshaping clinical and operational standards across regions. Stakeholders can leverage this report’s strategic guidance to refine their approach to market participation and advance maternal healthcare delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of heat-stable carbetocin formulations in low-resource settings to prevent postpartum hemorrhage
5.2. Ongoing clinical trials evaluating carbetocin safety and efficacy in cesarean and vaginal deliveries
5.3. Impact of WHO inclusion of heat-stable carbetocin on global procurement and funding policies
5.4. Collaborative partnerships between pharmaceutical companies and global health organizations to scale carbetocin access
5.5. Price negotiations and tiered pricing models improving affordability of carbetocin in emerging markets
5.6. Expansion of public-private procurement agreements to integrate carbetocin into national essential medicines lists
5.7. Technological innovations in drug delivery devices enhancing carbetocin administration in remote clinics
5.8. Regulatory approvals and fast-track designations for novel carbetocin analogs targeting postpartum hemorrhage reduction
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Carbetocin Market, by Indication
8.1. Introduction
8.2. Prevention Of Postpartum Hemorrhage
8.2.1. Cesarean Section
8.2.2. Vaginal Delivery
8.3. Treatment Of Postpartum Hemorrhage
8.3.1. Cesarean Section
8.3.2. Vaginal Delivery
9. Carbetocin Market, by Formulation
9.1. Introduction
9.2. Prefilled Syringe
9.3. Vial
10. Carbetocin Market, by Route Of Administration
10.1. Introduction
10.2. Intramuscular
10.3. Intravenous
11. Carbetocin Market, by End User
11.1. Introduction
11.2. Birthing Centers
11.3. Clinics
11.4. Hospitals
12. Carbetocin Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Retail Pharmacies
13. Americas Carbetocin Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Carbetocin Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Carbetocin Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Ferring Pharmaceuticals
16.3.2. Fresenius Kabi AG
16.3.3. Gland Pharma Limited
16.3.4. Intas Pharmaceuticals Limited
16.3.5. Merck & Co., Inc.
16.3.6. Pfizer Inc.
16.3.7. Haffkine Bio-Pharmaceutical Corporation Limited
16.3.8. Cipla Limited
16.3.9. Sun Pharmaceutical Industries Limited
16.3.10. Zhejiang Jingxin Pharmaceutical Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CARBETOCIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CARBETOCIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CARBETOCIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CARBETOCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARBETOCIN MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CARBETOCIN MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARBETOCIN MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARBETOCIN MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARBETOCIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARBETOCIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARBETOCIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CARBETOCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARBETOCIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CARBETOCIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CARBETOCIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CARBETOCIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CARBETOCIN MARKET: RESEARCHAI
FIGURE 26. CARBETOCIN MARKET: RESEARCHSTATISTICS
FIGURE 27. CARBETOCIN MARKET: RESEARCHCONTACTS
FIGURE 28. CARBETOCIN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CARBETOCIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARBETOCIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CARBETOCIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CARBETOCIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CARBETOCIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CARBETOCIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CARBETOCIN MARKET SIZE, BY VAGINAL DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CARBETOCIN MARKET SIZE, BY VAGINAL DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CARBETOCIN MARKET SIZE, BY VAGINAL DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CARBETOCIN MARKET SIZE, BY VAGINAL DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CARBETOCIN MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CARBETOCIN MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CARBETOCIN MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CARBETOCIN MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CARBETOCIN MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CARBETOCIN MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CARBETOCIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CARBETOCIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CARBETOCIN MARKET SIZE, BY BIRTHING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CARBETOCIN MARKET SIZE, BY BIRTHING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CARBETOCIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CARBETOCIN MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CARBETOCIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CARBETOCIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS CARBETOCIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES CARBETOCIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES CARBETOCIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 86. CANADA CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 87. CANADA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 88. CANADA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 89. CANADA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 90. CANADA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 91. CANADA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. CANADA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. MEXICO CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. MEXICO CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. MEXICO CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. GERMANY CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. GERMANY CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 174. GERMANY CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 175. GERMANY CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 176. GERMANY CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 177. GERMANY CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 178. GERMANY CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 179. GERMANY CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. GERMANY CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. GERMANY CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. GERMANY CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. GERMANY CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. GERMANY CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. FRANCE CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. FRANCE CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. FRANCE CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 188. FRANCE CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 189. FRANCE CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 192. FRANCE CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 193. FRANCE CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. FRANCE CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. FRANCE CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. FRANCE CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. FRANCE CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. FRANCE CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. ITALY CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. ITALY CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. ITALY CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 216. ITALY CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 217. ITALY CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 218. ITALY CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 219. ITALY CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 220. ITALY CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 221. ITALY CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. ITALY CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. ITALY CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ITALY CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. ITALY CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. ITALY CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. SPAIN CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. SPAIN CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. SPAIN CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 230. SPAIN CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 231. SPAIN CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 232. SPAIN CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 233. SPAIN CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 234. SPAIN CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 235. SPAIN CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. SPAIN CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. SPAIN CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. SPAIN CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SPAIN CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. SPAIN CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. DENMARK CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. DENMARK CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. DENMARK CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 286. DENMARK CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 287. DENMARK CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 288. DENMARK CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 289. DENMARK CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 290. DENMARK CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 291. DENMARK CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. DENMARK CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. DENMARK CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. DENMARK CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. DENMARK CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. DENMARK CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. NETHERLANDS CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. NETHERLANDS CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. QATAR CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. QATAR CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. QATAR CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 314. QATAR CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 315. QATAR CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 316. QATAR CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 317. QATAR CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 318. QATAR CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 319. QATAR CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. QATAR CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. QATAR CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. QATAR CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. QATAR CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. QATAR CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. FINLAND CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. FINLAND CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. FINLAND CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 328. FINLAND CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 329. FINLAND CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 330. FINLAND CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 331. FINLAND CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 332. FINLAND CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 333. FINLAND CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 334. FINLAND CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 335. FINLAND CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. FINLAND CARBETOCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. FINLAND CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. FINLAND CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. SWEDEN CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 340. SWEDEN CARBETOCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 341. SWEDEN CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 342. SWEDEN CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 343. SWEDEN CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2024 (USD MILLION)
TABLE 344. SWEDEN CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2025-2030 (USD MILLION)
TABLE 345. SWEDEN CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 346. SWEDEN CARBETOCIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 347. SWEDEN CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 348. SWEDEN CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 349. SWEDEN CARBETOCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350.

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Carbetocin market report include:
  • Ferring Pharmaceuticals
  • Fresenius Kabi AG
  • Gland Pharma Limited
  • Intas Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Haffkine Bio-Pharmaceutical Corporation Limited
  • Cipla Limited
  • Sun Pharmaceutical Industries Limited
  • Zhejiang Jingxin Pharmaceutical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 224.63 Million
Forecasted Market Value ( USD ) by 2030 $ 298.85 Million
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Carbetocin for Injection Market by Carbetocin for Injection Eligible Market Segments (Distribution Channel, End User, Indication) - Global Forecast 2025-2030 - Product Image

Carbetocin for Injection Market by Carbetocin for Injection Eligible Market Segments (Distribution Channel, End User, Indication) - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Carbetocin API Market by Application (Postpartum Hemorrhage Prevention, Uterine Atony Treatment), Administration Route (Intramuscular, Intravenous, Subcutaneous), Dosage Form, End User, Distribution Channel, Manufacturer Type - Global Forecast 2025-2030 - Product Image

Carbetocin API Market by Application (Postpartum Hemorrhage Prevention, Uterine Atony Treatment), Administration Route (Intramuscular, Intravenous, Subcutaneous), Dosage Form, End User, Distribution Channel, Manufacturer Type - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Carboprost Tromethamine - Global Strategic Business Report - Product Image

Carboprost Tromethamine - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
Oxytocin - Global Strategic Business Report - Product Image

Oxytocin - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
Carboprost Tromethamine Market Report 2025 - Product Image

Carboprost Tromethamine Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Carbetocin Market

Carbetocin is a synthetic oxytocin analogue used in the treatment of postpartum haemorrhage (PPH). It is a drug used in the field of Sexual and Reproductive Health (SRH) and is administered intravenously or intramuscularly. Carbetocin is used to reduce the risk of PPH, a major cause of maternal mortality and morbidity. It is also used to reduce the need for additional uterotonics and to reduce the risk of uterine atony. Carbetocin has been shown to be more effective than oxytocin in preventing PPH and has fewer side effects. Carbetocin is available in many countries, including the United States, Canada, Australia, and the United Kingdom. It is approved for use in the treatment of PPH in the United States and Canada. Some companies in the Carbetocin market include Ferring Pharmaceuticals, Pfizer, Merck, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.